The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain

Anesthesia and Analgesia

Volumn 89, Issue 1, 1999, Pages 136-142

  Belfrage, Måns ^a   Segerdahl, Märta ^b   Arnér, Staffan ^b   Sollevi, Alf ^b  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MALE; NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; SCORING SYSTEM; TOUCH; TREATMENT OUTCOME;

ADENOSINE; ADULT; CHRONIC DISEASE; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; PAIN;

EID: 0033050519     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199907000-00023     Document Type: Article

References (19)

1. Sawynok J, Sweeney MI. The role of purines in nociception. Neuroscience 1989;32:557-69.
2. Karlsten R, Gordh T, Hartvig P, Post C. Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat. Anesth Analg 1990;71:60-4.
3. Lee YW, Yaksh TL. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J Pharmacol Exp Ther 1996;277:1642-8.
4. Cui JG, Sollevi A, Linderoth B, Meyerson BA. Adenosine receptor activation suppresses tactile hypersensitivity and potentiates spinal cord stimulation in mononeuropathic rats. Neurosci Lett 1997;223:173-6.
5. Sjölund K-F, Sollevi A, Segerdahl M, et al. Intrathecal and systemic R-phenylisopropyl-adenosine reduces scratching behaviour in a rat mononeuropathy model. Neuroreport 1996;7: 1856-60.
6. 1 receptor agonist R-phenylisopropyl adenosine reduces presumed pain behaviour in a rat model of central pain. Neurosci Lett 1998;243:89-92.
7. Segerdahl M, Ekblom A, Sollevi A. The influence of adenosine, ketamine, and morphine on experimentally induced ischemic pain in healthy volunteers. Anesth Analg 1994;79:787-91.
8. Segerdahl M, Ekblom A, Sjölund K-F, et al. Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humans. Neuroreport 1995;6:753-6.
9. Sollevi A, Belfrage M, Lundeberg, T. Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain. Pain 1995;61:155-8.
10. Belfrage M, Sollevi A, Segerdahl, et al. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg 1995; 81:713-7.
11. Rane K, Segerdahl M, Goiny M, Sollevi A. Intrathecal adenosine administration: a phase 1 clinical safety study in healthy volunteers with evaluation of its influence on sensory thresholds. Anesthesiology 1998;89:1108-15.
12. Lindblom U, Nordfors L-O, Sollevi A, Sydow O. Adenosine for pain relief in a patient with intractable secondary erythromelalgia. Eur J Pain 1997;1:299-302.
13. 1-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth Analg 1995;80:844-7.
14. Karlsten R, Kristensen JD, Gordh T Jr. R-phenylisopropyl-adenosine increases spinal cord blood flow after intrathecal injection in the rat. Anesth Analg 1992;75:972-6.
15. Li J, Perl ER. Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J Neurophysiol 1994;72:1611-21.
16. MacDonald RL, Skerritt JH, Wertz MA. Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurons in cell culture. J Physiol 1986;370:75-90.
17. Sollevi A. Cardiovascular effects of adenosine in man: possible clinical implications. Prog Neurobiol 1986;27:319-49.
18. Dickenson AH. Spinal cord pharmacology of pain. Br J Anaesth 1995;75:193-200.
19. Salter MW, De Koninck Y, Henry JL. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog Neurobiol 1993;41:125-56.